Bone Biologics (BBLG) 10-K2023 FY Annual report

Filed: 21 Feb 24, 5:05pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: accessed, acknowledgment, advice, affirmatively, al, Albany, amortizable, anti, arrangement, automated, avenue, Benchmark, Bentley, Biogen, Bioscience, Blvd, Brendan, CA, charter, Clean, Codification, column, copy, Coulston, cybersecurity, Deloitte, dense, difficulty, discharge, disk, dismissed, division, Donate, dropping, Easton, EF, efficiently, encouraged, ensuing, extraordinary, fashion, fear, fit, footnote, fourth, fulfilling, Gagnon, Gurnet, hand, hard, Harvard, hedge, herewith, hour, Hutton, Idec, Intercompany, Ionic, Jeff, Jeffery, Keith, length, Lind, line, literacy, LLP, Maker, MIT, national, objective, ovine, panel, panic, preemptive, prejudice, proxy, Purple, qualitative, quickly, ratably, reclassified, Remix, residing, restore, retention, Robert, segment, Sloan, standing, subheading, summarized, suspected, telephone, threat, Touche, Treadway, twenty, uncontrolled, unfettered, unmet, unpaid, unregistered, unsound, unwanted, venture, Verastem, widespread, Wilshire

Removed: acquirer, adjust, adjusted, arbitrary, ASU, capacity, capitalization, Certification, charitable, collateral, commitment, concentration, consulting, continually, curtailing, defense, defer, deficiency, demonstration, displaying, diverge, eliminating, emerging, entirety, exert, exhibiting, explanatory, fifty, fixed, hope, impeding, interrupted, job, Letter, Linkbase, man, matching, maximum, measurable, original, OTCQB, outpatient, pose, positioned, prevailing, privately, recipient, reliably, resignation, retail, retained, retirement, returned, revised, Schema, settle, situation, sixty, speak, spread, strength, subjected, Subtopic, Sygnal, takeover, talent, Task, Taxonomy, terminology, TLIF, Transparency, transpire, unique, unissued, update, vigorously, whichever, XBRL

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

BBLG similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

Certification of Principal Financial Officer

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to

Section 906 of the Sarbanes-Oxley Act of 2002

In connection with the Report of Bone Biologics Corporation (the “Company”) on Form 10-K for the period ended December 31, 2023 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Deina H. Walsh, Principal Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	/s/ Deina H. Walsh
	Deina H. Walsh
	Principal Financial Officer

	February 21, 2024